Literature DB >> 6327867

In vitro release of lysozyme from monocytes and granulocytes.

B Haneberg, J Glette, I Talstad, S Sørnes, C O Solberg.   

Abstract

When exposed to zymosan or latex particles or heat-inactivated staphylococci, freshly prepared human blood monocytes and granulocytes rapidly released a large fraction of their lysozyme content. Within 24 hours the total lysozyme activity in the monocyte suspensions tripled, while it doubled in the granulocyte suspensions, indicating synthesis of the enzyme following release. The monocytes in particular seemed to release and synthesize lysozyme without any other stimulus than contact with lymphocytes and the tube walls. Potassium caseinate in solution did not influence the lysozyme release. Myeloperoxidase and beta-glucuronidase, which in the granulocytes are kept in lysosomal fractions separate from most of the lysozyme, were neither released nor synthesized to a significant degree. Moreover, the minute amount of lactate dehydrogenase released indicated that the lysozyme release was not the result of cell lysis. Accordingly, the monocytes, which are not already stimulated by adherence to nonphagocytosable surfaces, are capable of selective enzyme release similar to that of the granulocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327867     DOI: 10.1002/jlb.35.6.573

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  4 in total

1.  Effect of fusidic acid on migration and chemiluminescence of polymorphonuclear leukocytes.

Authors:  A Naess; R W Flø; C O Solberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

2.  Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis.

Authors:  J Dankert; J van der Werff; S A Zaat; W Joldersma; D Klein; J Hess
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

3.  A possible role for lysozyme in determining acute exacerbation in chronic bronchitis.

Authors:  D C Taylor; A W Cripps; R L Clancy
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

4.  Lipoprotein LprI of Mycobacterium tuberculosis Acts as a Lysozyme Inhibitor.

Authors:  Deepti Sethi; Sahil Mahajan; Chaahat Singh; Amrita Lama; Mangesh Dattu Hade; Pawan Gupta; Kanak L Dikshit
Journal:  J Biol Chem       Date:  2015-11-20       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.